NCI is asking for $6.38 billion for fiscal year 2019—nearly $1 billion, or 12 percent, above FY17 appropriation levels—to fully fund promising research areas.
How’s this for a paradox: The better cancer centers become at keeping patients alive, the more expensive cancer care becomes. This brutal tradeoff hits harder in rural areas, where the cancer burden is higher and the investigator and clinical trial representation is lower.
